BioSuperior has created a unique lipid nanoparticle (LNP) based on a naturally occurring biomaterial that is essential for breathing. Our LNP will be used to deliver disease-modifying treatments containing mRNA, antibodies, genes, and small molecules. We are in preclinical development on a novel anti-inflammatory therapeutic for use in bronchopulmonary dysplasia and plan to partner on novel treatments for respiratory, cardiovascular and neurological disease.